Galera Therapeutics (GRTX) Stock Chart & Stock Price History $0.02 +0.00 (+0.85%) As of 08/7/2025 03:15 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Galera Therapeutics Stock Price Performance The Galera Therapeutics (GRTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 64.57%, with a year-to-date return of -48.03%. In the past month, the stock has decreased 13.45%, reflecting recent market activity. As of the latest close, Galera Therapeutics traded at $0.02 with a market cap of $1.80 million and volume of 4,146 shares. Five years ago, the stock traded at $7.96, representing a 99.70% decrease over that period. At the time, it had a market cap of $196.90 million and a volume of 14,709 shares. Receive GRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.48%1 Month Performance-13.45%3 Month Performance+4.39%Year-To-Date Performance-48.03%1 Year Performance-64.57%5 Year Performance-99.70% GRTX Stock Chart for Friday, August, 8, 2025 GRTX Chart by TradingView Galera Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$0.02$0.02+3.48%$0.02$0.024,146 shs$1.80 million08/06/2025$0.02$0.02$0.02$0.0218,093 shs$1.74 million08/05/2025$0.02$0.02+2.22%$0.02$0.0235,716 shs$1.74 million08/04/2025$0.02$0.02-2.17%$0.02$0.02694 shs$1.70 million08/01/2025$0.02$0.02-4.17%$0.03$0.028,409 shs$1.74 million07/31/2025$0.03$0.02-7.69%$0.03$0.029,692 shs$1.81 million07/30/2025$0.02$0.03+5.69%$0.03$0.02158,664 shs$1.96 million07/29/2025$0.03$0.02-5.02%$0.03$0.02263,019 shs$1.86 million07/28/2025$0.03$0.03+3.60%$0.03$0.031,479 shs$1.95 million07/25/2025$0.02$0.03+5.93%$0.03$0.0258,672 shs$1.89 million Get the Latest News and Ratings for GRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$0.02$0.02-3.67%$0.03$0.02171,546 shs$1.78 million07/23/2025$0.02$0.02-0.81%$0.03$0.0214,951 shs$1.85 million07/22/2025$0.03$0.02-3.14%$0.03$0.02375,479 shs$1.86 million07/21/2025$0.03$0.03+1.19%$0.03$0.0381,103 shs$1.92 million07/18/2025$0.03$0.03-5.26%$0.03$0.0338,067 shs$1.90 million07/17/2025$0.03$0.03-11.04%$0.03$0.0340,433 shs$2.01 million07/16/2025$0.03$0.03-0.33%$0.03$0.0327,082 shs$2.26 million07/15/2025$0.03$0.03+15.38%$0.03$0.0326,100 shs$2.26 million07/14/2025$0.03$0.03-3.70%$0.03$0.0352,230 shs$1.96 million07/11/2025$0.03$0.03+1.50%$0.03$0.039,946 shs$2.04 million07/10/2025$0.03$0.03-6.34%$0.03$0.03270,617 shs$2.01 million07/09/2025$0.03$0.03+3.27%$0.03$0.0346,949 shs$2.14 million07/08/2025$0.03$0.03+5.77%$0.03$0.0317,290 shs$2.08 million07/07/2025$0.03$0.03-11.56%$0.03$0.0355,987 shs$1.96 million Related Companies CDIO Stock Chart ALZN Stock Chart MBIO Stock Chart MYNZ Stock Chart AEZS Stock Chart NLSP Stock Chart JBIO Stock Chart ARTL Stock Chart INAB Stock Chart SBFM Stock Chart Receive GRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GRTX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRTX Stock Alerts